Market Assessment, Friedreich's Ataxia Epidemiology Epidemiology Data Slicer Report

EPI Data Slicer

Friedreich's Ataxia - Epidemiology - Epidemiology Data Slicer
- Friedreich's Ataxia

Laura Darnieder

Laura Darnieder is a Business Insights Analyst on the Infectious, Niche, and Rare Diseases team at Decision Resources Group, where she is focused on providing market forecasts within the niche biopharmaceutical space.

Prior to joining DRG, Laura earned a Ph.D. in Neuroscience from Tufts University Sackler School of Graduate Biomedical Sciences. Her research focused on the role of stress neuropeptides and inhibitory signaling in alcohol dependence and drug addiction. She also holds a B.S., summa cum laude, in Psychobiology and Linguistics from Binghamton University (SUNY).

Back to all Market Assessment reports

Contact us

Investors

Careers

Login

Friedreich’s Ataxia – Epidemiology – Epidemiology Data Slicer

Table of contents

Related Market Assessment Reports

Osteoporosis – Landscape & Forecast – Disease Landscape & Forecast

Nonalcoholic Steatohepatitis – Current Treatment – Detailed, Expanded Analysis: Current Treatment: Physician Insights (US)

Breast Cancer – Geographic Focus: China – Breast Cancer – China In-Depth (China)

Non-Small-Cell Lung Cancer – Geographic Focus: China – Non-Small-Cell Lung Cancer – China In-Depth (China)

Renal Anemia – Current Treatment – Detailed, Expanded Analysis (US): Treatment Algorithms: Claims Data Analysis